SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer have?
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer has 11 citations in the OpenAlex counts ScholarIQ stores.
When was SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer published?
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer has 2025 year in the ScholarIQ index.
What is the open-access status of SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer?
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer has green oa status in the ScholarIQ index.
What is the DOI of SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer?
The DOI for SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer is on the source record.
What is the PMID of SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer?
The PMID for SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer is on the source record.
What is the OpenAlex record for SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer?
The OpenAlex for SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer is on the source record.